Galenica Santé’s CHF 1.9 billion initial public offering

The initial public offering of Galenica Santé, Switzerland’s leading fully integrated healthcare provider, was successfully completed.

In view of the strong demand, the price range had to be increased twice and the price could finally be fixed at CHF 39.

After the exercise of the over-allotment option (Greenshoe), the free float will amount to 100% and Galenica as the Selling Shareholder will hold only some rump shares for exchange. The market capitalization amounts to abound CHF 1.9 billion. Thus, YTD 2017 it is the largest IPO in Europe and the second largest IPO worldwide.

Citigroup, Credit Suisse and UBS were joint global coordinators and bookrunners to the issue. Deutsche Bank was also a joint bookrunner, with Baader Bank, Bank am Bellevue, Bank Vontobel and Zuercher Kantonalbank named as co-lead managers.

Kellerhals Carrard acted as lead counsel on the transaction with a team led by Dr. Beat Brechbühl (picture) and Dr. Christian Witschi, assisted by Dr. Emanuel Dettwiler, Dr. Edgar Philippin, Ines Pöschel, Philippe Frésard, Kathrin Enderli, Alexander Schütz, Sophie Holdt, Susanne Brütsch and Cristina Castellote.


Involved fees earner: Beat Brechbühl – Kellerhals Carrard; Edgar Philippin – Kellerhals Carrard; Emanuel Dettwiler – Kellerhals Carrard; Alexander Schütz – Kellerhals Carrard; Ines Pöschel – Kellerhals Carrard; Sophie Holdt – Kellerhals Carrard; Philippe Frésard – Kellerhals Carrard; Kathrin Enderli – Kellerhals Carrard;

Law Firms: Kellerhals Carrard;

Clients: Galenica Santé Ltd.;